BUFFALO, N.Y. -- Schering-Plough has provided $125,000 to the
University at Buffalo School of Pharmacy and Pharmaceutical
Sciences to fund the training of a graduate fellow in the school's
Pharmaceutics Program. The gift, which will come in $25,000
increments over five years, will support a stipend, tuition and
research funding for the student over a five-year period.
The first student selected for the fellowship is Eliza Tsou, a
graduate of the National Taiwan University. Tsou, whose thesis is
"Biochemical Mechanisms of Nitroglycerin Tolerance and Metabolism,"
is collaborating on the research with Ho-Leung Fung, Ph.D.,
professor in the Department of Pharmaceutical Sciences.
"The Schering-Plough Research Institute, the research and
development arm of Schering-Plough Corporation, anticipates
increased demand for qualified pharmaceutical scientists in order
to bring new medical entities through the research and development
pipeline to patients with unmet medical needs," said Richard A.
Morrison, Ph.D., executive director of drug metabolism and
pharmacokinetics at Schering-Plough, who received his doctorate in
pharmaceutics from UB in 1983.
"In addition to providing monetary support for a prospective
doctoral candidate, this funding will encourage increased
intellectual collaboration with UB professors and provide a
recruiting conduit for identifying highly-trained scientists."
Morrison, who was instrumental in securing the gift for the
school, added: "The pharmaceutics department at the University at
Buffalo is recognized for advancing the pharmaceutical sciences and
providing highly trained and motivated students for the
pharmaceutical industry and academia. As an alumnus of the
department, I am personally grateful for the excellent training
that I received, and I am happy that Schering-Plough has provided
Wayne K. Anderson, dean of the UB School of Pharmacy and
Pharmaceutical Sciences, said, "Schering-Plough recognizes the need
to increase the number of graduates to meet the demands of industry
and academia for Ph.D.-trained individuals in pharmacokinetics,
pharmacodynamics and pharmacogenetics. We can expand our
leading-edge research programs, the outcome of which will benefit
the drug development and discovery activities of Schering-Plough
According to William J. Jusko, Ph.D., professor and chair of
UB's Department of Pharmaceutical Sciences, the program's graduates
are in great demand by the pharmaceutical industry, Food and Drug
Administration and other universities: "Our program attracts a
large number of applicants from all over the world, but we can only
afford to accept six to eight people each year. This gift will
allow us to train one additional doctoral student over the typical
study period of five years."
Ranked among the top pharmacy schools in the United States and
considered one of the most prestigious, the School of Pharmacy and
Pharmaceutical Sciences was founded in 1886, and is the
second-oldest component of the University at Buffalo and the only
pharmacy school in the State University of New York system.
The University at Buffalo is a premier research-intensive
public university, the largest and most comprehensive campus in the
State University of New York. The School of Pharmacy and
Pharmaceutical Sciences is one of five schools that constitute UB's
Academic Health Center.